illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. RPG Life Sciences
Company logo

RPG Life Sciences | Sustainability Performance

https://www.rpglifesciences.com/website/index.php

Engages in pharmaceutical research, manufacturing, and sales. Activities include product development, clinical testing, and distribution of medicines, with a focus on healthcare delivery and regulatory compliance.

1968

India

1,001 - 5,000 employees

Pharmaceuticals

$25M - 100M in revenue

$10M - 25M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#6074
Overall
#143
in India
#139
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

253 out of 292

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Solara Active Pharma Sciences

India, Health Care, Pharmaceuticals


Company logo
Ipca Laboratories

India, Health Care, Pharmaceuticals


Company logo
Jubilant Pharmova

India, Health Care, Pharmaceuticals

Market cap

38.8B $, 2026▼7.8% YoY

Revenue

6.5B $, 2025▼10.9% YoY

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

38.8B $, 2026▼7.8% YoY

Revenue

6.5B $, FY2025▼10.9% YoY

EBITDA

1.6B $, FY2025▼9.1% YoY

Operating margin

21% Industry: -33▼9.8% YoY

P/E ratio

20.8 Industry: 26▲98% YoY

Revenue & EBITDA

$6.5BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

418.3M 2025▼39.9% YoY

Capex

360.0M 2025▲92.2% YoY

Return on invested capital

35.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

5.1

2023

5.8

2024

6.5

2025

NaN


Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

60%
Independent Directors

9 out of 15 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


Total sustainability employees

2-3


    Available in
    Scale package

    Access
  • Email

  • Email